Skip to main content
. 2023 Jul 18;38(12):2733–2742. doi: 10.1093/ndt/gfad167

Figure 4:

Figure 4:

PERR and CRR at week 104 in patients with and without GC pulses at induction (mITT population; post hoc analyses). OR and 95% CI values are from a logistic regression model run within the subgroup level for the comparison between belimumab and placebo with covariates treatment group, induction regimen (CYC versus MMF), race (Black African ancestry versus other), baseline UPCR and baseline eGFR.